Developmental Dynamics · 2006 · 118 citations · 50 references
Life SciencesCell BiologyMolecular BiologyCell SignalingEnzymologyGene ExpressionExtracellular MatrixHeart DevelopmentProteolytic EnzymesProteolytic ProcessingCardiac Cushion DevelopmentEndocardial Cushion DevelopmentEpithelial-mesenchymal TransformationExtracellular ProteasesMatrix MetalloproteinasesPrimary ProteolysisProteolysis ProductsProteolytic Profiles
The proteoglycan versican is essential to the formation of endocardial cushion mesenchyme by epithelial-mesenchymal transformation (EMT). A potentially important factor in the regulation of versican activity during cushion EMT is proteolysis by ADAMTS metalloproteinases. Using antibodies to the DPEAAE neoepitope created by ADAMTS proteolysis of versican, we detected the amino terminal 70-kDa versican cleavage fragment in cardiac cushions. Initially (i.e., 9.5 days post coitum [dpc]), the fragment is associated with endocardial cells undergoing EMT and with newly derived mesenchymal cells. ADAMTS-1 and its cofactor fibulin-1 were also associated with these cells. As cushions become increasingly populated with mesenchymal cells (10.5-12.5 dpc), the fragment remains asymmetrically distributed compared with the pattern of total versican. Highest levels of the fragment are present in regions immediately subjacent to the endocardium characterized as having densely packed, rounded cells, lacking cellular protrusions. With further development (i.e., 12.5-14.5 dpc), the pattern of fragment distribution within cushions broadens to include the ECM surrounding loosely packed mesenchymal cells in the cushion core. Together, the findings reveal that versican proteolysis leading to the production of the 70-kDa fragment is integral to the formation and differentiation of endocardial cushion mesenchyme.
50
Primer3 on the WWW for General Users and for Biologist Programmers
Steve Rozen, Helen Skaletsky · Humana Press eBooks · 2003 · 15.1K citations
Todd D. Camenisch, Andrew P. Spicer, Tammy Brehm-Gibson et al. · Journal of Clinical Investigation · 2000 · 897 citations · Full text
John D. Sandy, Jennifer Westling, Richard D. Kenagy et al. · Journal of Biological Chemistry · 2001 · 457 citations · Full text